TRMB three-lens brief
Evidence-based stock research on TRMB. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $90.58 — 34% above current (12 analysts). · Debt-to-equity of 26.7 — balance-sheet-heavy.
- Analyst mean target $90.58 — 34% above current (12 analysts).
- Debt-to-equity of 26.7 — balance-sheet-heavy.
TRMB closed at $67.35 (+0.46%) as of 2026-04-25. Market cap: $15.63B. P/E (trailing) 38.3. Positives: analyst mean target $90.58 — 34% above current (12 analysts).. Concerns: debt-to-equity of 26.7 — balance-sheet-heavy.. Last quarter: Revenue $969.80M, net income $156.60M, free cash flow $522.81M.
Why three lenses on TRMB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine TRMBacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/TRMB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath TRMB brief"></iframe>